← Leaderboards
Nicholas Colangelo
Rbhs-New Jersey Medical School
$155,567
Attributed
$155,567
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $50K · FY2017–20$100K$75K$50K$25K$0
'17
'18
'19
'20
Funding mix
By agency
NIH$155,567 · 1
By mechanism
F30$155,567 · 1
Top collaborators
No co-investigators on record.
Most similar at Rbhs-New Jersey Medical School
Same institution · by research overlap
- Madeleine Hu$77,039
Others in their field
Other Emerging Leaders on “Adult”
- Beth Baseler · Leidos Biomedical Research, Inc.$127,607,354
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$93,592,175
- Susan M Landau · University Of California Berkeley$47,252,026
- Marlene Ann Cooper · Harvard University D/B/A Harvard School Of Public Health$42,295,422
- Nancy Roche · Leidos Biomedical Research, Inc.$39,999,252
- Evan Z Macosko · Broad Institute, Inc.$32,116,761
Research focus
AdultAstrocytesBrainBrain NeoplasmsCancer CellCancer TypeCarcinomaCellsChemoradiationConditioned Culture MediaEnvironmentExcisionExperimental StudyExtracellular MatrixExtracellular VesiclesFibroblastsGlioblastomaGliomaImage GuidedImproved OutcomeInhibitor/AntagonistIntercellular CommunicationInvadedAdjuvant
Grant awards (4)
The Role of CD147 in Glioblastoma Invasiveness$28,827
F30 · FY2020 · CA · contact PI
The Role of CD147 in Glioblastoma Invasiveness$50,016
F30 · FY2019 · CA · contact PI
The Role of CD147 in Glioblastoma Invasiveness$38,602
F30 · FY2018 · CA · contact PI
The Role of CD147 in Glioblastoma Invasiveness$38,122
F30 · FY2017 · CA · contact PI